Conversational Voice Assistant-Enhanced for Loneliness

Phase-Based Progress Estimates
Eastmont Senior Living Apartments, Lincoln, NE
Loneliness+2 More
Conversational Voice Assistant-Standard - Behavioral
All Sexes
What conditions do you have?

Study Summary

Building upon existing evidence on loneliness and pain research, conversational voice assistant (CVA)technology and personalized persuasion, we have assembled an interdisciplinary and inter-institutional team of researchers to conduct a 12-week randomized control pilot with older adults that live alone and self-report pain. Participants will interact with a standard or a personally enhanced loneliness routine delivered through a CVA. We will explore intervention feasibility and examine the efficacy of both standard and personalized interventions on loneliness and secondary outcomes. Inclusion: 1) men and women 60 years of age; 2) live alone (single-family home, independent, or assisted living); 3) self-report have experienced or currently experiencing musculoskeletal pain; and 4) wireless internet access via a broadband Internet connection. Exclusion: 1) memory loss as evidenced by poor performance on the Mini Cog; 2) inability to speak English; 3) prior study participation; 4) prior use or current use of a conversational voice assistant; and 5) not willing to engage with the voice assistant. Our proposed study is comprised of 1) a one week pre-study session for participant equipment set-up, training, and baseline pre- study data collection; 2) a 12-week randomized trial of the standard or the enhanced CVA delivered interventions; and 3) a one-week post-study data collection.

Eligible Conditions

  • Loneliness
  • Pain, Chronic

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

3 Primary · 4 Secondary · Reporting Duration: at day one and after 12-weeks

Week 12
UCLA Loneliness Scale
University of California Los Angeles (UCLA) Loneliness Scale
Week 12
Brief Pain Inventory
after 12 weeks
Customer Satisfaction
at day one and after 12-weeks
Depressive symptoms
Self-efficacy of managing pain

Trial Safety

Safety Progress

1 of 3

Trial Design

2 Treatment Groups

Conversational Voice Assistant-Enhanced
1 of 2
Conversational Voice Assistant-Standard
1 of 2
Experimental Treatment

60 Total Participants · 2 Treatment Groups

Primary Treatment: Conversational Voice Assistant-Enhanced · No Placebo Group · N/A

Conversational Voice Assistant-Enhanced
Experimental Group · 1 Intervention: Conversational Voice Assistant-Enhanced · Intervention Types: Behavioral
Conversational Voice Assistant-Standard
Experimental Group · 1 Intervention: Conversational Voice Assistant-Standard · Intervention Types: Behavioral

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: at day one and after 12-weeks

Trial Background

Prof. Marcia Shade, Assistant Professor
Principal Investigator
University of Nebraska
Closest Location: Eastmont Senior Living Apartments · Lincoln, NE
N/AFirst Recorded Clinical Trial
1 TrialsResearching Loneliness
0 CompletedClinical Trials

Eligibility Criteria

Age 18+ · All Participants · 1 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.